A Multifunctional Neutralizing Antibody‐Conjugated Nanoparticle Inhibits and Inactivates SARS‐CoV‐2-Reference-Cited by-同舟云学术

A Multifunctional Neutralizing Antibody‐Conjugated Nanoparticle Inhibits and Inactivates SARS‐CoV‐2

Published:2021-11-10 Issue:2 Volume:9 Page:2103240
ISSN:2198-3844
Container-title:Advanced Science
language:en
Short-container-title:Advanced Science

Author:

Cai Xiaolei¹^ORCID,Chen Min¹,Prominski Aleksander²,Lin Yiliang²,Ankenbruck Nicholas¹,Rosenberg Jillian³,Nguyen Mindy¹,Shi Jiuyun²,Tomatsidou Anastasia⁴,Randall Glenn⁴,Missiakas Dominique⁴,Fung John⁵,Chang Eugene B.⁶,Penaloza‐MacMaster Pablo⁷,Tian Bozhi²,Huang Jun¹^ORCID

Affiliation:

1. Pritzker School of Molecular Engineering University of Chicago Chicago IL 60637 USA

2. Department of Chemistry University of Chicago Chicago IL 60637 USA

3. Committee on Cancer Biology University of Chicago Chicago IL 60637 USA

4. Department of Microbiology Howard Taylor Ricketts Laboratory University of Chicago Chicago IL 60637 USA

5. Department of Surgery University of Chicago Chicago IL 60637 USA

6. Department of Medicine University of Chicago Chicago IL 60637 USA

7. Department of Microbiology‐Immunology Northwestern University Chicago IL 60611 USA

Funder

National Institutes of Health

National Science Foundation

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Wiley

Subject

General Physics and Astronomy,General Engineering,Biochemistry, Genetics and Molecular Biology (miscellaneous),General Materials Science,General Chemical Engineering,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/advs.202103240

Reference98 articles.

1. Critical Supply Shortages — The Need for Ventilators and Personal Protective Equipment during the Covid-19 Pandemic

2. COVID-19 pandemic: perspectives on an unfolding crisis

3. Global rise in human infectious disease outbreaks

4. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2

5. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revolutionary Pyrazole‐based Aza‐BODIPY: Harnessing Photothermal Power Against Cancer Cells and Bacteria;ChemBioChem;2024-01-09

2. A novel nanocomposite drug delivery system for SARS-CoV-2 infections;Nanoscale Advances;2024

3. Phytochemical-loaded Nanoparticles in COVID-19 Management;Natural Resources for Human Health;2023-12-07

4. Brain‐Targeted Liposomes Loaded with Monoclonal Antibodies Reduce Alpha‐Synuclein Aggregation and Improve Behavioral Symptoms in Parkinson's Disease;Advanced Materials;2023-10-27

5. Advances in In Vitro Blood-Air Barrier Models and the Use of Nanoparticles in COVID-19 Research;Tissue Engineering Part B: Reviews;2023-09-26